1. Scriver, C. R. & Kaufman, S. in The Metabolic and Molecular Bases Of Inherited Disease 8th edn (eds Scriver, C.R., Baudet, A.L., Valle, D., & Sly, W.S.) 1667–1724 (McGraw-Hill, New York, 2001).
2. Aoki, K. & Wada, Y. Outcome of the patients detected by newborn screening in Japan. Acta Paediatr. Jpn. 30, 429–434 (1988).
3. Bickel, H., Bachmann, C., Beckers, R., Brandt, N. J., Clayton, B. E., Corrado, G. et al. Neonatal mass screening for metabolic disorders: summary of recent sessions of the committee of experts to study inborn metabolic diseases, public health committee, council of Europe. Eur. J. Pediatr. 137, 133–139 (1981).
4. Liu, S. R. & Zuo, Q. H. Newborn screening for phenylketonuria in eleven districts. Chin. Med. J. 99, 113–118 (1986).
5. Lee, D. H., Koo, S. K., Lee, K. S., Yeon, Y. J., Oh, H. J., Kim, S. W. et al. The molecular basis of phenylketonuria in Koreans. J. Hum. Genet. 49, 617–621 (2004).